The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Intravenous(IV) Therapy and Vein Access-Global Market Insights and Sales Trends 2024
Synopsis
IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
The global Intravenous(IV) Therapy and Vein Access market size is expected to reach US$ 46480 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Intravenous(IV) Therapy and Vein Access in various end use industries. The expanding demands from the Hospital, Clinics and Other, are propelling Intravenous(IV) Therapy and Vein Access market. Infusion Pumps, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Implantable Ports segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intravenous(IV) Therapy and Vein Access, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intravenous(IV) Therapy and Vein Access market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intravenous(IV) Therapy and Vein Access market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intravenous(IV) Therapy and Vein Access sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intravenous(IV) Therapy and Vein Access covered in this report include B. Braun, Baxter International, Becton Dickinson, C. R. Bard, Fresenius Kabi, Hospira(ICU Medical), Medtronic, Smiths Group and Teleflex, etc.
The global Intravenous(IV) Therapy and Vein Access market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Global Intravenous(IV) Therapy and Vein Access market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous(IV) Therapy and Vein Access market, Segment by Type:
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Global Intravenous(IV) Therapy and Vein Access market, by Application
Hospital
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Intravenous(IV) Therapy and Vein Access companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
The global Intravenous(IV) Therapy and Vein Access market size is expected to reach US$ 46480 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Intravenous(IV) Therapy and Vein Access in various end use industries. The expanding demands from the Hospital, Clinics and Other, are propelling Intravenous(IV) Therapy and Vein Access market. Infusion Pumps, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Implantable Ports segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intravenous(IV) Therapy and Vein Access, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intravenous(IV) Therapy and Vein Access market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intravenous(IV) Therapy and Vein Access market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intravenous(IV) Therapy and Vein Access sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intravenous(IV) Therapy and Vein Access covered in this report include B. Braun, Baxter International, Becton Dickinson, C. R. Bard, Fresenius Kabi, Hospira(ICU Medical), Medtronic, Smiths Group and Teleflex, etc.
The global Intravenous(IV) Therapy and Vein Access market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Global Intravenous(IV) Therapy and Vein Access market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous(IV) Therapy and Vein Access market, Segment by Type:
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Global Intravenous(IV) Therapy and Vein Access market, by Application
Hospital
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Intravenous(IV) Therapy and Vein Access companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Intravenous(IV) Therapy and Vein Access
1.1 Intravenous(IV) Therapy and Vein Access Market Overview
1.1.1 Intravenous(IV) Therapy and Vein Access Product Scope
1.1.2 Intravenous(IV) Therapy and Vein Access Market Status and Outlook
1.2 Global Intravenous(IV) Therapy and Vein Access Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Intravenous(IV) Therapy and Vein Access Market Size by Region (2018-2029)
1.4 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Region (2018-2023)
1.5 Global Intravenous(IV) Therapy and Vein Access Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.1 North America Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.2 Europe Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.4 Latin America Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.5 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
2 Intravenous(IV) Therapy and Vein Access Market by Type
2.1 Introduction
2.1.1 Infusion Pumps
2.1.2 Implantable Ports
2.1.3 Intravenous Catheters
2.1.4 Hypodermic Needles
2.1.5 Other
2.2 Global Intravenous(IV) Therapy and Vein Access Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Type (2018-2023)
2.2.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
3 Intravenous(IV) Therapy and Vein Access Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Other
3.2 Global Intravenous(IV) Therapy and Vein Access Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Application (2018-2023)
3.2.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
4 Intravenous(IV) Therapy and Vein Access Competition Analysis by Players
4.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous(IV) Therapy and Vein Access as of 2022)
4.3 Date of Key Players Enter into Intravenous(IV) Therapy and Vein Access Market
4.4 Global Top Players Intravenous(IV) Therapy and Vein Access Headquarters and Area Served
4.5 Key Players Intravenous(IV) Therapy and Vein Access Product Solution and Service
4.6 Competitive Status
4.6.1 Intravenous(IV) Therapy and Vein Access Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 B. Braun
5.1.1 B. Braun Profile
5.1.2 B. Braun Main Business
5.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.1.4 B. Braun Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.1.5 B. Braun Recent Developments
5.2 Baxter International
5.2.1 Baxter International Profile
5.2.2 Baxter International Main Business
5.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.2.4 Baxter International Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.2.5 Baxter International Recent Developments
5.3 Becton Dickinson
5.3.1 Becton Dickinson Profile
5.3.2 Becton Dickinson Main Business
5.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.3.4 Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.3.5 C. R. Bard Recent Developments
5.4 C. R. Bard
5.4.1 C. R. Bard Profile
5.4.2 C. R. Bard Main Business
5.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.4.4 C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.4.5 C. R. Bard Recent Developments
5.5 Fresenius Kabi
5.5.1 Fresenius Kabi Profile
5.5.2 Fresenius Kabi Main Business
5.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.5.4 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.5.5 Fresenius Kabi Recent Developments
5.6 Hospira(ICU Medical)
5.6.1 Hospira(ICU Medical) Profile
5.6.2 Hospira(ICU Medical) Main Business
5.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.6.4 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.6.5 Hospira(ICU Medical) Recent Developments
5.7 Medtronic
5.7.1 Medtronic Profile
5.7.2 Medtronic Main Business
5.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.7.4 Medtronic Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.7.5 Medtronic Recent Developments
5.8 Smiths Group
5.8.1 Smiths Group Profile
5.8.2 Smiths Group Main Business
5.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.8.4 Smiths Group Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.8.5 Smiths Group Recent Developments
5.9 Teleflex
5.9.1 Teleflex Profile
5.9.2 Teleflex Main Business
5.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.9.4 Teleflex Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.9.5 Teleflex Recent Developments
6 North America
6.1 North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Intravenous(IV) Therapy and Vein Access Market Dynamics
11.1 Intravenous(IV) Therapy and Vein Access Industry Trends
11.2 Intravenous(IV) Therapy and Vein Access Market Drivers
11.3 Intravenous(IV) Therapy and Vein Access Market Challenges
11.4 Intravenous(IV) Therapy and Vein Access Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
